Ngā hua rapu - Sandra E. Ghayad
- E whakaatu ana i te 1 - 10 hua o te 10
-
1
-
2
mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene‐expression levels mā Sandra E. Ghayad, Ivan Bièche, Julie A. Vendrell, Céline Keime, Rosette Lidereau, Charles Dumontet, Pascale A. Cohen
I whakaputaina 2008Artigo -
3
Exosomes derived from embryonal and alveolar rhabdomyosarcoma carry differential miRNA cargo and promote invasion of recipient fibroblasts mā Sandra E. Ghayad, Ghina Rammal, Farah Ghamloush, Hussein Basma, Rihab Nasr, Mona Diab‐Assaf, Claude Chelala, Raya Saab
I whakaputaina 2016Artigo -
4
Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer mā Sandra E. Ghayad, Julie A. Vendrell, Ivan Bièche, Frédérique Spyratos, Charles Dumontet, Isabelle Treilleux, Rosette Lidereau, Pascale A. Cohen
I whakaputaina 2008Artigo -
5
The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486 mā Farah Ghamloush, Sandra E. Ghayad, Ghina Rammal, Assil Fahs, Abeer J. Ayoub, Zeina Merabi, Mohamad Harajly, Hassan Zalzali, Raya Saab
I whakaputaina 2019Artigo -
6
HSV-1 cellular model reveals links between aggresome formation and early step of Alzheimer’s disease mā Marie Alexandra Albaret, Julien Textoris, Bastien Dalzon, Jérémy Lambert, Morgane Linard, Catherine Helmer, Sabine Hacot, Sandra E. Ghayad, M. Ferréol, Hichem C. Mertani, Jean‐Jacques Diaz
I whakaputaina 2023Revisão -
7
Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence of <i>de novo</i> or acquired resistance and importance... mā Paul Vilquin, Marie Villedieu, Evelyne Grisard, Sabrina Ben Larbi, Sandra E. Ghayad, Pierre-Étienne Heudel, Thomas Bachelot, Laura Corbo, Isabelle Treilleux, Julie A. Vendrell, Pascale A. Cohen
I whakaputaina 2013Artigo -
8
ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion mā Julie A. Vendrell, Aurélie Thollet, Nhan Trung Nguyen, Sandra E. Ghayad, Stéphanie Vinot, Ivan Bièche, Evelyne Grisard, Véronique Josserand, Jean‐Luc Coll, Pierre Roux, Laura Corbo, Isabelle Treilleux, Ruth Rimokh, Pascale A. Cohen
I whakaputaina 2012Artigo -
9
Evidence for rRNA 2′-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes mā Jenny Erales, Virginie Marchand, Baptiste Panthu, Sandra Gillot, Stéphane Belin, Sandra E. Ghayad, Maxime Garcia, Florian Laforêts, Virginie Marcel, Agnès Baudin‐Baillieu, Pierre Bertin, Yohann Couté, Annie Adrait, Mélanie Meyer, Gabriel Thérizols, Marat Yusupov, Olivier Namy, Théophile Ohlmann, Yuri Motorin, Frédéric Catez, Jean‐Jacques Diaz
I whakaputaina 2017Artigo -
10
p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer mā Virginie Marcel, Sandra E. Ghayad, Stéphane Belin, Gabriel Thérizols, Anne-Pierre Morel, Eduardo Solano-Gonzàlez, Julie A. Vendrell, Sabine Hacot, Hichem C. Mertani, Marie Alexandra Albaret, Jean‐Christophe Bourdon, Lee B. Jordan, Alastair Thompson, Yasmine Tafer, Rong Cong, Philippe Bouvet, Jean-Christophe Saurin, Frédéric Catez, Anne‐Catherine Prats, Alain Puisieux, Jean‐Jacques Diaz
I whakaputaina 2013Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Cancer research
Cancer
Cell biology
Genetics
Medicine
Breast cancer
Gene
Internal medicine
Computational biology
Estrogen receptor
Protein kinase B
Signal transduction
Bioinformatics
Business
Cell cycle
Methylation
Microvesicles
PI3K/AKT/mTOR pathway
Pathology
Ribosomal RNA
Tamoxifen
microRNA
5.8S ribosomal RNA
Aggresome
Alveolar rhabdomyosarcoma
Alzheimer's disease
Amyloid (mycology)
Amyloid precursor protein
Anastrozole